Busca un médico

Kenneth R. Olivier, M.D.

Solicite una Consulta

Publicaciones

  1. Kowalchuk RO, Mullikin TC, Spears GM, Johnson-Tesch BA, Rose PS, Siontis BL, Kun Kim D, Costello BA, Morris JM, Gao RW, Shiraishi S, Lucido JJ, Olivier KR, Owen D, Stish BJ, Waddle MR, Laack NN, Park SS, Brown PD, Merrell KW. Assessment of minimum target dose as a predictor of local failure after spine SBRT. Radiother Oncol. 2024 Jun; 195:110260 Epub 2024 Mar 27
    View PubMed
  2. Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, Ashman JB, Schild SE, Grams MP, Lucido JJ, Shen KR, Cassivi SD, Wigle D, Nichols FC, Blackmon S, Tapias LF, Callstrom MR, Owen D. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Chest. 2024 May; 165 (5):1247-1259 Epub 2023 Dec 14
    View PubMed
  3. Kowalchuk RO, Mullikin TC, Florez M, De BS, Spears GM, Rose PS, Siontis BL, Kim DK, Costello BA, Morris JM, Marion JT, Johnson-Tesch BA, Gao RW, Shiraishi S, Lucido JJ, Trifiletti DM, Olivier KR, Owen D, Stish BJ, Waddle MR, Laack NN, Park SS, Brown PD, Ghia AJ, Merrell KW. Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy. Cancer. 2023 Mar 15; 129(6):956-965. Epub 2022 Dec 26.
    View PubMed
  4. Domsic RT, Pokrzywinski R, Stassek L, Benton WW, Vampola CL, Furst DE, Chung L, Steen V, Mayes MD, Shah AA, Molitor JA, Oliver K, Nagaraja V, Khanna D. Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis. ACR Open Rheumatol. 2023 Mar; 5 (3):132-141 Epub 2023 Feb 02
    View PubMed
  5. Piccinin C, Basch E, Bhatnagar V, Calvert M, Campbell A, Cella D, Cleeland CS, Coens C, Darlington AS, Dueck AC, Groenvold M, Herold R, King-Kallimanis BL, Kluetz PG, Kulis D, O'Connor D, Oliver K, Pe M, Reeve BB, Reijneveld JC, Wang XS, Bottomley A. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group. Lancet Oncol. 2023 Feb; 24 (2):e86-e95
    View PubMed
  6. Kowalchuk R, Mullikin TC, Breen W, Gits HC, Florez M, De B, Harmsen WS, Rose PS, Siontis BL, Costello BA, Morris JM, Lucido JJ, Olivier KR, Stish B, Laack NN, Park S, Owen D, Ghia AJ, Brown PD, Merrell KW. Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy. Front Oncol. 2023; 13:1095170 Epub 2023 Mar 27
    View PubMed
  7. Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 Dec; 23 (8):e526-e535 Epub 2022 Aug 10
    View PubMed
  8. Madani I, Sahgal A, Erler D, Stish BJ, Olivier KR, Park SS, Eppinga WSC, Seravalli E, Redmond KJ, Cao Y, Siva S, Chang D, Nguyen TK, O'Neil M, Guckenberger M. Stereotactic Body Radiation Therapy for Metastases in Long Bones. Int J Radiat Oncol Biol Phys. 2022 Nov 15; 114 (4):738-746 Epub 2022 July 16
    View PubMed
  9. Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13
    View PubMed
  10. Kowalchuk RO, Mullikin TC, Harmsen WS, Rose PS, Siontis BL, Kim DK, Costello BA, Morris JM, Marion JT, Johnson-Tesch BA, Gao RW, Shiraishi S, Lucido JJ, Olivier KR, Owen D, Stish BJ, Laack NN, Park SS, Brown PD, Merrell KW. Development and internal validation of a recursive partitioning analysis-based model predictive of pain flare incidence after spine stereotactic body radiation therapy. Practical Radiation Oncology. 2022 Jul-aug; 12 (4):E269-77
  11. Millward CP, Armstrong TS, Barrington H, Brodbelt AR, Bulbeck H, Byrne A, Dirven L, Gamble C, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Krishna ST, Mallucci CL, Marson AG, McDermott MW, Meling TR, Oliver K, Pizer B, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD. Opportunities and challenges for the development of "core outcome sets" in neuro-oncology. Neuro Oncol. 2022 Jul 1; 24 (7):1048-1055
    View PubMed
  12. Galanis E, Giannini C, James D, Kaufmann TJ, Lachance D, Millward CP, Armstrong TS, Barrington H, Bell S, Brodbelt AR, Bulbeck H, Crofton A, Dirven L, Georgious T, Grundy PL, Islim AI, Javadpour M, Keshwara SM, Koszdin SD, Marson AG, McDermott MW, Meling TR, Oliver K, Plaha P, Preusser M, Santarius T, Srikandarajah N, Taphoorn MJB, Turner C, Watts C, Weller M, Williamson PR, Zadeh G, Zamanipoor Najafabadi AH, Jenkinson MD, EORTC BTG, ICOM, EANO, SNO, RANO-PRO, BNOS, SBNS, BIMS, TBTC, International Brain Tumour Alliance, Brainstrust, and Brain Tumour Foundation of Canada. Development of 'Core Outcome Sets' for Meningioma in Clinical Studies (The COSMIC Project): protocol for two systematic literature reviews, eDelphi surveys and online consensus meetings. BMJ Open. 2022 May 9; 12 (5):e057384 Epub 2022 May 09
    View PubMed
  13. Angirekula M, Chang SY, Jenkins SM, Greipp PT, Sukov WR, Marks RS, Olivier KR, Cassivi SD, Roden AC. CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma. Cancers (Basel). 2022 May 5; 14 (9) Epub 2022 May 05
    View PubMed
  14. Stewart GA, Breen WG, Stish BJ, Mullikin TC, Park SS, Olivier KR, Costello BA. Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern Era. Clin Genitourin Cancer. 2022 Apr; 20 (2):107-113 Epub 2021 Nov 10
    View PubMed
  15. Kowalchuk RO, Johnson-Tesch BA, Marion JT, Mullikin TC, Harmsen WS, Rose PS, Siontis BL, Kim DK, Costello BA, Morris JM, Gao RW, Shiraishi S, Lucido JJ, Sio TT, Trifiletti DM, Olivier KR, Owen D, Stish BJ, Waddle MR, Laack NN, Park SS, Brown PD, Merrell KW. Development and Assessment of a Predictive Score for Vertebral Compression Fracture After Stereotactic Body Radiation Therapy for Spinal Metastases. JAMA Oncol. 2022 Mar 01; 8(3):412-419.
    View PubMed
  16. Kowalchuk RO, Mullikin TC, Harmsen WS, Rose PS, Siontis BL, Kim DK, Costello BA, Morris JM, Marion JT, Johnson-Tesch BA, Gao RW, Shiraishi S, Lucido JJ, Olivier KR, Owen D, Stish BJ, Laack NN, Park SS, Brown PD, Merrell KW. Development and Internal Validation of a Recursive Partitioning Analysis-Based Model Predictive of Pain Flare Incidence After Spine Stereotactic Body Radiation Therapy. Pract Radiat Oncol. 2022 Jul-Aug; 12(4):e269-e277. Epub 2022 Feb 10.
    View PubMed
  17. Gergelis KR, Anand US, Rian JS, Roberts KW, Quinones PJ, Olivier KR, Corbin KS, Stonnington CM. Integrating a Grassroots Well-Being Curriculum into a Radiation Oncology Residency Program. Adv Radiat Oncol. 2022 Jan-Feb; 7 (1):100837 Epub 2021 Oct 27
    View PubMed
  18. Lucido JJ, Mullikin TC, Abraha F, Harmsen WS, Vaishnav BD, Brinkmann DH, Kowalchuk RO, Marion JT, Johnson-Tesch BA, El Sherif O, Brown PD, Rose PS, Owen D, Morris JM, Waddle MR, Siontis BL, Stish BJ, Pafundi DH, Laack NN, Olivier KR, Park SS, Merrell KW. Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy. Adv Radiat Oncol. 2022 Nov-Dec; 7(6):101047. Epub 2022 Aug 13.
    View PubMed
  19. Voisin MR, Oliver K, Farrimond S, Chee T, O'Halloran P, Glas M, Zadeh G, International Brain Tumour Alliance (IBTA) Senior Advisors. Brain tumor patients and COVID-19 vaccines: results of an international survey. Neurooncol Adv. 2022 Jan-Dec; 4 (1):vdac063 Epub 2022 May 03
    View PubMed
  20. Zhang H, Orme JJ, Abraha F, Stish BJ, Lowe VJ, Lucien F, Tryggestad EJ, Bold MS, Pagliaro LC, Choo CR, Brinkmann DH, Iott MJ, Davis BJ, Quevedo JF, Harmsen WS, Costello BA, Johnson GB, Nathan MA, Olivier KR, Pisansky TM, Kwon ED, Dong H, Park SS. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in (11)C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2021 Dec 1; 27 (23):6376-6383 Epub 2021 Sept 30
    View PubMed
  21. Arbab M, Holmes JA, Olivier KR, Fields EC, Corbin KS, Kahn JM, Zellars RC, Haywood AM. Integrating Radiation Oncology Into Undergraduate Medical Education. Adv Radiat Oncol. 2021 Nov-Dec; 6 (6):100765 Epub 2021 July 28
    View PubMed
  22. Deek MP, Taparra K, Phillips R, Velho PI, Gao RW, Deville C, Song DY, Greco S, Carducci M, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, Paller CJ, Antonarakis ES, Olivier KR, Park SS, Tran PT, Stish BJ. Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer. Eur Urol Oncol. 2021 Jun; 4 (3):447-455 Epub 2020 June 11
    View PubMed
  23. Breen WG, Jeans EB, Gergelis KR, Garces YI, Park SS, Merrell KW, Peikert TD, Mansfield AS, Wigle DA, Harmsen WS, Ellerbusch DC, Olivier KR, John Lucido J, Owen D. Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity. Radiother Oncol. 2021 May; 158:246-252 Epub 2021 Mar 10
    View PubMed
  24. Deek MP, Taparra K, Dao D, Chan L, Phillips R, Gao RW, Kwon ED, Deville C, Song DY, Greco S, Carducci MA, Eisenberger M, DeWeese TL, Denmeade S, Pienta K, Paller CJ, Antonarakis ES, Olivier KR, Park SS, Stish BJ, Tran PT. Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer. Int J Radiat Oncol Biol Phys. 2021 Feb 1; 109 (2):387-395 Epub 2020 Aug 14
    View PubMed
  25. Ebner DK, Taparra K, Olivier KR. The Game Continues: Seeking Clarity in the Radiation Oncology Match. Adv Radiat Oncol. 2021 Mar-Apr; 6(2):100627. Epub 2020 Nov 23.
    View PubMed
  26. Jimenez RB, Johnson A, Padilla L, Yechieli R, Forman R, Horick N, Thomas H, Gunther JR, Olivier K, Golden DW, Fields E, Radiation Oncology Education Collaborative Study Group. The Impact of an Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees Across the United States and Canada. Int J Radiat Oncol Biol Phys. 2020 Jul 1; 107 (3):408-416 Epub 2020 Feb 11
    View PubMed
  27. Jethwa KR, Jang S, Mullikin TC, Harmsen WS, Petersen MM, Olivier KR, Park SS, Neben-Wittich MA, Hubbard JM, Sandhyavenu H, Whitaker TJ, Waltman LA, Kipp BR, Merrell KW, Haddock MG, Hallemeier CL. Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer. Radiother Oncol. 2020 May; 146:29-36 Epub 2020 Feb 27
    View PubMed
  28. Breen WG, Garces YI, Olivier KR, Park SS, Merrell KW, Nichols FC, Peikert TD, Molina JR, Mansfield AS, Roden AC, Blackmon SH, Wigle DA. Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience. Front Oncol. 2020; 10:392 Epub 2020 Mar 24
    View PubMed
  29. Kharofa J, Tendulkar R, Fields E, Beriwal S, Attia A, Olivier K. Cleaning without SOAP: How Program Directors Should Respond to Going Unmatched in 2020. Int J Radiat Oncol Biol Phys 2020 Feb 1; 106 (2):241-242
    View PubMed
  30. Burmeister J, Buatti J, Jimenez R, Marcrom S, Olivier K, Price M, Wallner P. Exam Preparation and Performance Reporting Changes for the American Board of Radiology Radiation Oncology Physics Examination: Results From the ASTRO Workgroup. Int J Radiat Oncol Biol Phys 2020 Jan 1; 106 (1):43-44 Epub 2019 Oct 21
    View PubMed
  31. Jenkins R, LeBlanc A, Oliver K, Penas-Prado M, Wu J, Cahill DP, Brat DJ, Costello JF, Kluetz PG, Cairncross JG, van den Bent M, Verhaak RGW, Aboud O, Burger P, Chang SM, Cordova C, Huang RY, Rowe LS, Taphoorn MJB, Gilbert MR, Armstrong TS, NCI-CONNECT Oligodendroglioma Workshop. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop. Neurooncol Adv. 2020 Jan-Dec; 2 (1):vdz048 Epub 2019 Dec 06
    View PubMed
  32. Kazemi NY, Jain C, Bois MC, Behfar A, Olivier K, Markovic SN. Heart Block Caused by Cardiac Metastasis From Merkel Cell Carcinoma: A Case Report. Mayo Clin Proc Innov Qual Outcomes. 2019 Dec; 3 (4):510-516 Epub 2019 Nov 22
    View PubMed
  33. Jethwa KR, Hellekson CD, Evans JD, Harmsen WS, Wilhite TJ, Whitaker TJ, Park SS, Choo CR, Stish BJ, Olivier KR, Haloi R, Lowe VJ, Welch BT, Quevedo JF, Mynderse LA, Karnes RJ, Kwon ED, Davis BJ. (11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities. Adv Radiat Oncol. 2019 Oct-Dec; 4 (4):659-667 Epub 2019 July 04
    View PubMed
  34. Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Suescun JBG, McGarry RC, Choy H, Bradley JD. Long-term follow-up on nrg oncology rtog 0915 (ncctg n0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer International Journal Of Radiation Oncology Biology Physics. 2019 Apr 1; 103 (5):1077-84
  35. Gao RW, Olivier KR, Park SS, Davis BJ, Pisansky TM, Choo R, Kwon ED, Karnes RJ, Harmsen WS, Stish BJ. Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases. Adv Radiat Oncol. 2019 Apr-Jun; 4 (2):314-322 Epub 2019 Feb 19
    View PubMed
  36. Arnett ALH, Mou B, Owen D, Park SS, Nelson K, Hallemeier CL, Sio T, Garces YI, Olivier KR, Merrell KW. Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC. Adv Radiat Oncol. 2019 Apr-Jun; 4 (2):422-428 Epub 2019 Jan 24
    View PubMed
  37. Videtic GM, Paulus R, Singh AK, Chang JY, Parker W, Olivier KR, Timmerman RD, Komaki RR, Urbanic JJ, Stephans KL, Yom SS, Robinson CG, Belani CP, Iyengar P, Ajlouni MI, Gopaul DD, Gomez Suescun JB, McGarry RC, Choy H, Bradley JD. Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2019 Apr 1; 103 (5):1077-1084 Epub 2018 Dec 01
    View PubMed
  38. Evans JD, Brown PD, Olivier KR. Stereotactic Spinal Radiosurgery and Delayed Vertebral Fracture Risk. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):20-25 Epub 2018 Sept 19
    View PubMed
  39. Shiraishi S, Fong de Los Santos LE, Antolak JA, Olivier KR, Garces YI, Park SS, Grams MP. Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Pract Radiat Oncol. 2019 Jan; 9 (1):29-37 Epub 2018 Aug 20
    View PubMed
  40. Evans JD, Morris LK, Zhang H, Cao S, Liu X, Mara KC, Stish BJ, Davis BJ, Mansfield AS, Dronca RS, Iott MJ, Kwon ED, Foote RL, Olivier KR, Dong H, Park SS. Prospective Immunophenotyping of CD8(+) T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT. Int J Radiat Oncol Biol Phys. 2019 Jan 1; 103 (1):229-240 Epub 2018 Sept 08
    View PubMed
  41. Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro JZ, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schurmann C, Smith AW, Soltys KM, Sridhara R, Taphoorn MJB, Velikova G, Coens C. Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials. Clin Trials. 2018 Dec; 15 (6):624-630 Epub 2018 Aug 24
    View PubMed
  42. Pe M, Dorme L, Coens C, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dirven L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Sloan J, Velikova G, Bottomley A, Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium (SISAQOL). Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. Lancet Oncol. 2018 Sep; 19 (9):e459-e469
    View PubMed
  43. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26
    View PubMed
  44. Ravishankar A, Park SS, Olivier KR, Corbin KS. Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature. Case Rep Oncol. 2018 Jan-Apr; 11 (1):168-178 Epub 2018 Mar 27
    View PubMed
  45. Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Pract Radiat Oncol. 2017 Nov - Dec; 7 (6):e531-e541 Epub 2017 Apr 19
    View PubMed
  46. Youland RS, Blanchard ML, Dronca R, Kottschade L, Markovic SN, Olivier KR, Park SS. Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era. Clin Transl Radiat Oncol. 2017 Oct; 6:25-30 Epub 2017 Sept 30
    View PubMed
  47. Youland RS, Packard AT, Blanchard MJ, Arnett AL, Wiseman GA, Kottschade LA, Dronca RS, Markovic SN, Olivier KR, Park SS. 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma. Adv Radiat Oncol. 2017 Apr-Jun; 2 (2):204-210 Epub 2017 Feb 24
    View PubMed
  48. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71 (3):340-348 Epub 2016 Sept 03
    View PubMed
  49. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 1; 97 (3):526-535 Epub 2016 Nov 17
    View PubMed
  50. Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. Adv Radiat Oncol. 2017 Jan-Mar; 2 (1):12-18 Epub 2016 Dec 21
    View PubMed
  51. Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdom Radiol (NY). 2016 Oct; 41 (10):2061-77
    View PubMed
  52. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6 (4):e117-e126 Epub 2016 Jan 26
    View PubMed
  53. Muldermans JL, Romak LB, Kwon ED, Park SS, Olivier KR. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 Jun 1; 95 (2):696-702 Epub 2016 Jan 29
    View PubMed
  54. Grams MP, Fong de Los Santos LE, Antolak JA, Brinkmann DH, Clarke MJ, Park SS, Olivier KR, Whitaker TJ. Cadaveric verification of the Eclipse AAA algorithm for spine SBRT treatments with titanium hardware. Pract Radiat Oncol. 2016 Mar-Apr; 6: (2)131-41.
    View PubMed
  55. Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, Henderson D, Casamassima F, Orecchia R, Surgo A, Brown L, Tree A, Miralbell R, De Meerleer G. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. Eur Urol. 2016 Jan; 69 (1):9-12 Epub 2015 July 16
    View PubMed
  56. Merrell KW, Johnson JE, Mou B, Barney BM, Nelson KE, Mayo CS, Haddock MG, Hallemeier CL, Olivier KR. Stereotactic body radiotherapy for primary and metastatic liver tumors - the Mayo Clinic experience. J Radiosurg SBRT. 2016; 4 (2):133-144
    View PubMed
  57. Owen D, Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Adv Radiat Oncol. 2016 Jan-Mar; 1 (1):76-81 Epub 2015 Dec 19
    View PubMed
  58. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93 (4):757-64 Epub 2015 July 17
    View PubMed
  59. Blanchard M, Shim KG, Grams MP, Rajani K, Diaz RM, Furutani KM, Thompson J, Olivier KR, Park SS, Markovic SN, Pandha H, Melcher A, Harrington K, Zaidi S, Vile R. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Int J Radiat Oncol Biol Phys. 2015 Nov 1; 93 (3):577-87 Epub 2015 July 26
    View PubMed
  60. Stish BJ, Hallemeier CL, Olivier KR, Harmsen WS, Allen MS, Garces YI. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer. Clin Lung Cancer. 2015 Sep; 16: (5)e67-73.
    View PubMed
  61. Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. J Palliat Med. 2015 Aug; 18: (8)707-10.
    View PubMed
  62. Park SS, Dong H, Liu X, Harrington SM, Krco CJ, Grams MP, Mansfield AS, Furutani KM, Olivier KR, Kwon ED. PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Cancer Immunol Res. 2015 Jun; 3 (6):610-9 Epub 2015 Feb 19
    View PubMed
  63. Owen D, Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015 Feb 18; 10:43
    View PubMed
  64. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. Separating the dosimetric consequences of changing tumor anatomy from positional uncertainty for conventionally fractionated lung cancer patients. Pract Radiat Oncol. 2014 Nov-Dec; 4 (6):455-65 Epub 2014 Apr 03
    View PubMed
  65. Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN. Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):705-6. Epub 2014 Sep 26.
    View PubMed
  66. Hegg RM, Kurup AN, Schmit GD, Weisbrod AJ, Atwell TD, Olivier KR, Moynihan TJ, Callstrom MR. Cryoablation of sternal metastases for pain palliation and local tumor control. J Vasc Interv Radiol. 2014 Nov; 25(11):1665-70. Epub 2014 Sep 23.
    View PubMed
  67. Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep 8; 15 (5):4931 Epub 2014 Sept 08
    View PubMed
  68. Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, Lohse CM, Kohli M, Costello BA, Olivier KR, Thompson RH, Boorjian SA, Atwell TD. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014 Aug; 192 (2):357-63 Epub 2014 Mar 12
    View PubMed
  69. Frechette KM, Brown LC, Aubry MC, Wigle DA, Olivier KR. Pseudoprogression after stereotactic body radiotherapy. J Thorac Oncol. 2014 Apr; 9(4):e29-30.
    View PubMed
  70. Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4 (2):e143-e149 Epub 2013 June 29
    View PubMed
  71. Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014; 2014:418270 Epub 2014 Dec 09
    View PubMed
  72. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4:376 Epub 2015 Jan 14
    View PubMed
  73. Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors. Pract Radiat Oncol. 2014 Jan-Feb; 4 (1):35-42 Epub 2013 Mar 26
    View PubMed
  74. Saito AI, Olivier KR, Li JG, Liu C, Newlin HE, Schmalfuss I, Kyogoku S, Dempsey JF. Lung tumor motion change during stereotactic body radiotherapy (SBRT): An evaluation using MRI. J appl clin med phys. 2014; 15(3):25-31.
  75. Mou B, Beltran CJ, Park SS, Olivier KR, Furutani KM. Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. PLoS One. 2014; 9 (6):e98621 Epub 2014 June 02
    View PubMed
  76. Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36 (5):509-13
    View PubMed
  77. Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 1; 87 (1):73-80
    View PubMed
  78. Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol. 2013 Jul 06; 8:167.
    View PubMed
  79. Seder CW, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Olivier KR, Shen KR, Wigle DA. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16. Epub 2013 Mar 29.
    View PubMed
  80. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, Garcia JJ, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Pract Radiat Oncol. 2013 Apr-Jun; 3: (2)e71-7.
    View PubMed
  81. Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Frontiers in Oncology. 2013; 2 JAN:215.
  82. Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. J Radiosurg SBRT. 2013; 2 (3):225-233
    View PubMed
  83. Mayo CS, Zankowski C, Herman M, Miller R, Olivier K, Vincent A, Suominen J. A method to vectorize the dose distribution, the dose volume histogram and create a dose vector histogram. Med Phys. 2013 Jan; 40: (1)011717.
    View PubMed
  84. G Peacock J, A Call J, R Olivier K. Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma. Rare Tumors. 2013; 5 (3):e28 Epub 2013 July 09
    View PubMed
  85. Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am J Clin Oncol. 2012 Dec; 35 (6):537-42
    View PubMed
  86. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2012 July 10
    View PubMed
  87. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23 (11):2919-2924 Epub 2019 Dec 04
    View PubMed
  88. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012 Oct 22; 7:174
    View PubMed
  89. Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012 May 3; 7:67 Epub 2012 May 03
    View PubMed
  90. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82 (5):e803-9 Epub 2012 Feb 11
    View PubMed
  91. Saito AI, Li JG, Liu C, Olivier KR, Kyougoku S, Dempsey JF. Intravenous contrast agent influence on thoracic computed tomography simulation investigated through a heterogeneous dose calculation method using 5-bulk densities. Am J Clin Oncol. 2012 Apr; 35(2):110-4.
    View PubMed
  92. Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82 (3):1122-7 Epub 2011 May 11
    View PubMed
  93. Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol. 2012; 2:215. Epub 2013 Jan 22.
    View PubMed
  94. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011 May; 99 (2):166-71 Epub 2011 May 14
    View PubMed
  95. Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, Liu C, Chvetsov AV, Olivier K. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. Am J Clin Oncol. 2011 Feb; 34(1):16-21.
    View PubMed
  96. Yeung AR, Li J, Shi W, Newlin H, Morris CG, Samant S, Saito A, Chvetsov A, Liu C, Palta J, Olivier K. Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors. Am J Clin Oncol. 2010 Jun; 33(3):276-80.
    View PubMed
  97. Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, Olivier KR. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol. 2010 Apr; 33(2):153-6.
    View PubMed
  98. Vargas C, Saito AI, Hsi WC, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol. 2010 Feb; 33(1):11-6.
    View PubMed
  99. Yeung AR, Li JG, Shi W, Newlin HE, Chvetsov A, Liu C, Palta JR, Olivier K. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1100-7. Epub 2009 Apr 22.
    View PubMed
  100. Amdur RJ, Bennett J, Olivier K, Wallace A, Morris CG, Liu C, Mendenhall WM. A Prospective, Phase II Study Demonstrating the Potential Value and Limitation of Radiosurgery for Spine Metastases. Am J Clin Oncol. 2009 Jun 12. [Epub ahead of print]
    View PubMed
  101. Chang DT, Mendenhall NP, Lynch JW, Morris CG, Olivier KR. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol. 2009 Jun; 32(3):233-7.
    View PubMed
  102. Newlin HE, Iyengar M, Morris CG, Olivier K. Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):370-6. Epub 2009 Apr 06.
    View PubMed
  103. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr; 32(2):180-6.
    View PubMed
  104. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  105. Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. Accurate heterogeneous dose calculation for lung cancer patients without high-resolution CT densities. J Appl Clin Med Phys. 2009; 10(2):2847. Epub 2009 Apr 30.
    View PubMed
  106. Chang D, Pacholke H, Amdur R, Mendenhall N, Morris C, Byer G, Olivier KR. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: A potential role for parotid-sparing techniques? American Journal of Clinical Oncology. 2009.
  107. Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1426-33. Epub 2008 Aug 30.
    View PubMed
  108. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):744-51. Epub 2007 Sep 27.
    View PubMed
  109. Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol. 2007 Dec; 30(6):601-6.
    View PubMed
  110. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1110-6.
    View PubMed
  111. Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer. 2007 Oct 15; 110(8):1791-5.
    View PubMed
  112. Chang D, Liu C, Dempsey JF, Palta JR, Kopea J, Louis D, Morris C, Chopra R, Olivier KR. Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol. 2007 Feb; 30(1):57-62.
    View PubMed
  113. Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Int J Radiat Oncol Biol Phys. 2006 Dec 1; 66(5):1440-5. Epub 2006 Sep 25.
    View PubMed
  114. Chopra R, Mendenhall WM, Morris CG, Zlotecki RA, Olivier KR. Surgery and postoperative radiotherapy for adenoid cystic carcinoma of the lung. Am J Clin Oncol. 2006 Aug; 29(4):420-1.
    View PubMed
  115. Chang DT, Olivier KR, Morris CG, Liu C, Dempsey JF, Benda RK, Palta JR. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2006 May 1; 65(1):125-31. Epub 2006 Jan 19.
    View PubMed
  116. Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol. 2006 Apr; 29(2):202-6.
    View PubMed
  117. Chang DT, Zlotecki RA, Olivier KR. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am J Clin Oncol. 2005 Dec; 28(6):597-602.
    View PubMed
  118. Mora GR, Olivier KR, Mitchell RF, Jenkins RB, Tindall DJ. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate. Prostate. 2005 May 1; 63(2):198-207.
    View PubMed
  119. Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2004 Dec 1; 60(5):1510-4.
    View PubMed
  120. Mora GR, Olivier KR, Cheville JC, Mitchell RF Jr, Lingle WL, Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. Mol Cancer Res. 2004 Feb; 2(2):115-28.
    View PubMed
  121. Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res. 2002 Oct 1; 62 (19):5495-504
    View PubMed
  122. Kruse JJ, Herman MG, Hagness CR, Davis BJ, Garces YI, Haddock MG, Olivier KR, Stafford SL, Pisansky TM. Electronic and film portal images: a comparison of landmark visibility and review accuracy. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54 (2):584-91
    View PubMed
  123. Crittenden MR, Gough MJ, Harrington K, Olivier KR, Thompson J, Vile RG. Expression of Inflammatory Cytokines Combines with Local Tumor Destruction Enhances Tumor Regression and Long-term Immunity. Cancer Research. 2002; 63:5505-5512.
PST-20222399